title: Response.
authors.affiliation: Affiliations of authors: Department of Medical Oncology, Monash University at Cabrini Hospital, Malvern, Victoria, Australia (IEH); Secure Genetics, Newport Beach, New South Wales, Australia (GLGM).
authors.forename: Ian E
authors.initials: IE
authors.lastname: Haines
authors.forename: George L
authors.initials: GL
authors.lastname: Gabor Miklos
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000401:mortality*; D057832:Watchful Waiting
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen